Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans.

biomarkers myocardial infarction pharmacokinetics troponin

Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
10 Sep 2024
Historique:
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 10 9 2024
Statut: aheadofprint

Résumé

Cardiac troponin (cTn) is key in diagnosing myocardial infarction (MI). After MI, the clinically observed half-life of cTn has been reported to be 7 to 20 hours, but this estimate reflects the combined elimination and simultaneous release of cTn from cardiomyocytes. More precise timing of myocardial injuries necessitates separation of these 2 components. We used a novel method for determination of isolated cTn elimination kinetics in humans. Patients with MI were included within 24 hours after revascularization and underwent plasmapheresis to obtain plasma with a high cTn concentration. After at least 3 weeks, patients returned for an autologous plasma retransfusion followed by blood sampling for 8 hours. cTn was measured with 5 different high-sensitivity cTn assays. Of 25 included patients, 20 participants (mean age, 64.5 years; SD, 8.2 years; 4 women [20%]) received a retransfusion after a median of 5.8 weeks (interquartile range, 5.0-6.9 weeks) after MI. After retransfusion of a median of 620 mL (range, 180-679 mL) autologous plasma, the concentration of cTn in participants' blood increased 4 to 445 times above the upper reference level of the 5 high-sensitivity cTn assays. The median elimination half-life ranged from 134.1 minutes (95% CI, 117.8-168.0) for the Elecsys high-sensitivity cTnT assay to 239.7 minutes (95% CI, 153.7-295.1) for the Vitros high-sensitivity cTnI assay. The median clearance of cTnI ranged from 40.3 mL/min (95% CI, 32.0-44.9) to 52.7 mL/min (95% CI, 42.2-57.8). The clearance of cTnT was 77.0 mL/min (95% CI, 45.2-95.0). This novel method showed that the elimination half-life of cTnI and cTnT was 5 to 16 hours shorter than previously reported. This indicates a considerably longer duration of cardiomyocyte cTn release after MI than previously thought. Improved knowledge of timing of myocardial injury may call for changes in the management of MI and other disorders with myocardial injury.

Sections du résumé

BACKGROUND UNASSIGNED
Cardiac troponin (cTn) is key in diagnosing myocardial infarction (MI). After MI, the clinically observed half-life of cTn has been reported to be 7 to 20 hours, but this estimate reflects the combined elimination and simultaneous release of cTn from cardiomyocytes. More precise timing of myocardial injuries necessitates separation of these 2 components. We used a novel method for determination of isolated cTn elimination kinetics in humans.
METHODS UNASSIGNED
Patients with MI were included within 24 hours after revascularization and underwent plasmapheresis to obtain plasma with a high cTn concentration. After at least 3 weeks, patients returned for an autologous plasma retransfusion followed by blood sampling for 8 hours. cTn was measured with 5 different high-sensitivity cTn assays.
RESULTS UNASSIGNED
Of 25 included patients, 20 participants (mean age, 64.5 years; SD, 8.2 years; 4 women [20%]) received a retransfusion after a median of 5.8 weeks (interquartile range, 5.0-6.9 weeks) after MI. After retransfusion of a median of 620 mL (range, 180-679 mL) autologous plasma, the concentration of cTn in participants' blood increased 4 to 445 times above the upper reference level of the 5 high-sensitivity cTn assays. The median elimination half-life ranged from 134.1 minutes (95% CI, 117.8-168.0) for the Elecsys high-sensitivity cTnT assay to 239.7 minutes (95% CI, 153.7-295.1) for the Vitros high-sensitivity cTnI assay. The median clearance of cTnI ranged from 40.3 mL/min (95% CI, 32.0-44.9) to 52.7 mL/min (95% CI, 42.2-57.8). The clearance of cTnT was 77.0 mL/min (95% CI, 45.2-95.0).
CONCLUSIONS UNASSIGNED
This novel method showed that the elimination half-life of cTnI and cTnT was 5 to 16 hours shorter than previously reported. This indicates a considerably longer duration of cardiomyocyte cTn release after MI than previously thought. Improved knowledge of timing of myocardial injury may call for changes in the management of MI and other disorders with myocardial injury.

Identifiants

pubmed: 39253802
doi: 10.1161/CIRCULATIONAHA.123.066565
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Jonas Henrik Kristensen (JH)

Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark. (J.H.K., R.B.H., N.S., N.J., K.K.I.).
Department of Emergency Medicine, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark. (J.H.K., R.B.H., N.S., N.J., K.K.I.).
Department of Clinical Medicine, University of Copenhagen, Denmark. (J.H.K., R.B.H., N.S., S.A., M.D., N.R.J., J.K., K.D., H.B., K.K.I.).

Rasmus Bo Hasselbalch (RB)

Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark. (J.H.K., R.B.H., N.S., N.J., K.K.I.).
Department of Emergency Medicine, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark. (J.H.K., R.B.H., N.S., N.J., K.K.I.).
Department of Clinical Medicine, University of Copenhagen, Denmark. (J.H.K., R.B.H., N.S., S.A., M.D., N.R.J., J.K., K.D., H.B., K.K.I.).

Nina Strandkjær (N)

Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark. (J.H.K., R.B.H., N.S., N.J., K.K.I.).
Department of Emergency Medicine, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark. (J.H.K., R.B.H., N.S., N.J., K.K.I.).
Department of Clinical Medicine, University of Copenhagen, Denmark. (J.H.K., R.B.H., N.S., S.A., M.D., N.R.J., J.K., K.D., H.B., K.K.I.).

Nicoline Jørgensen (N)

Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark. (J.H.K., R.B.H., N.S., N.J., K.K.I.).
Department of Emergency Medicine, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark. (J.H.K., R.B.H., N.S., N.J., K.K.I.).

Morten Østergaard (M)

Cardiothoracic Anaesthesiology, Copenhagen University Hospital-Rigshospitalet, Denmark. (M.Ø. P.H.M.-S., J.C.N.).

Peter Hasse Møller-Sørensen (PH)

Cardiothoracic Anaesthesiology, Copenhagen University Hospital-Rigshospitalet, Denmark. (M.Ø. P.H.M.-S., J.C.N.).

Jens Christian Nilsson (JC)

Cardiothoracic Anaesthesiology, Copenhagen University Hospital-Rigshospitalet, Denmark. (M.Ø. P.H.M.-S., J.C.N.).

Shoaib Afzal (S)

Department of Clinical Biochemistry, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark. (S.A., P.R.K.).
Department of Clinical Medicine, University of Copenhagen, Denmark. (J.H.K., R.B.H., N.S., S.A., M.D., N.R.J., J.K., K.D., H.B., K.K.I.).

Pia Rørbæk Kamstrup (PR)

Department of Clinical Biochemistry, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark. (S.A., P.R.K.).

Morten Dahl (M)

Department of Clinical Medicine, University of Copenhagen, Denmark. (J.H.K., R.B.H., N.S., S.A., M.D., N.R.J., J.K., K.D., H.B., K.K.I.).
Department of Clinical Biochemistry, Zealand University Hospital-Køge, Denmark (M.D.).

Mustafa Vakur Bor (MV)

Department of Clinical Biochemistry, University Hospital of Southern Denmark, Esbjerg (M.V.B.).

Ruth Frikke-Schmidt (R)

Clinical Biochemistry, Copenhagen University Hospital-Rigshospitalet, Denmark. (R.F.-S., N.R.J., L.R.).

Niklas Rye Jørgensen (NR)

Department of Clinical Medicine, University of Copenhagen, Denmark. (J.H.K., R.B.H., N.S., S.A., M.D., N.R.J., J.K., K.D., H.B., K.K.I.).
Clinical Biochemistry, Copenhagen University Hospital-Rigshospitalet, Denmark. (R.F.-S., N.R.J., L.R.).

Line Rode (L)

Clinical Biochemistry, Copenhagen University Hospital-Rigshospitalet, Denmark. (R.F.-S., N.R.J., L.R.).

Lene Holmvang (L)

Departments of Cardiology, Copenhagen University Hospital-Rigshospitalet, Denmark. (L.H., J.K., L.E.B., H.B.).

Jesper Kjærgaard (J)

Department of Clinical Medicine, University of Copenhagen, Denmark. (J.H.K., R.B.H., N.S., S.A., M.D., N.R.J., J.K., K.D., H.B., K.K.I.).
Departments of Cardiology, Copenhagen University Hospital-Rigshospitalet, Denmark. (L.H., J.K., L.E.B., H.B.).

Lia Evi Bang (LE)

Departments of Cardiology, Copenhagen University Hospital-Rigshospitalet, Denmark. (L.H., J.K., L.E.B., H.B.).

Julie Forman (J)

Section of Biostatistics, Department of Public Health, University of Copenhagen, Denmark. (J.F.).

Kim Dalhoff (K)

Department of Clinical Medicine, University of Copenhagen, Denmark. (J.H.K., R.B.H., N.S., S.A., M.D., N.R.J., J.K., K.D., H.B., K.K.I.).
Department of Clinical Pharmacology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark (K.D.).

Allan S Jaffe (AS)

Departments of Cardiology and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MI (A.S.J.).

Kristian Thygesen (K)

Department of Cardiology, Aarhus University Hospital, Denmark (K.T.).
Department of Medine, Aarhus University, Denmark (K.T.).

Henning Bundgaard (H)

Department of Clinical Medicine, University of Copenhagen, Denmark. (J.H.K., R.B.H., N.S., S.A., M.D., N.R.J., J.K., K.D., H.B., K.K.I.).
Departments of Cardiology, Copenhagen University Hospital-Rigshospitalet, Denmark. (L.H., J.K., L.E.B., H.B.).

Kasper Karmark Iversen (KK)

Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark. (J.H.K., R.B.H., N.S., N.J., K.K.I.).
Department of Emergency Medicine, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark. (J.H.K., R.B.H., N.S., N.J., K.K.I.).
Department of Clinical Medicine, University of Copenhagen, Denmark. (J.H.K., R.B.H., N.S., S.A., M.D., N.R.J., J.K., K.D., H.B., K.K.I.).

Classifications MeSH